Cumberland Pharmaceuticals

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.16

+0.11 (+3.61%)

As of Mar 24, 5:00 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,021.8% upside

Low Target $27.92

Average Target $35.45

High Target $53.56

Current Price $3.16

Current
$3.16

Target
$35.45

$27.92 $35.45 avg $53.56

Scenario Analysis

Bear Case

$27.92

783.5%

Low target

Base Case

$35.45

+1,021.8%

Avg target

Bull Case

$53.56

+1,594.9%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$6.27

-49.6% from high

52-Week Low

$1.85

+70.8% from low

Target vs 52W High

$35.45

+465.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%